HRP970308B1 - Peptide derivatives - Google Patents

Peptide derivatives

Info

Publication number
HRP970308B1
HRP970308B1 HR970308A HRP970308A HRP970308B1 HR P970308 B1 HRP970308 B1 HR P970308B1 HR 970308 A HR970308 A HR 970308A HR P970308 A HRP970308 A HR P970308A HR P970308 B1 HRP970308 B1 HR P970308B1
Authority
HR
Croatia
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Application number
HR970308A
Other languages
English (en)
Inventor
Ronald Cotton
Philip Neil Edwards
Richard William Artur Luke
Keith Oldham
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9611881.5A external-priority patent/GB9611881D0/en
Priority claimed from GBGB9622890.3A external-priority patent/GB9622890D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HRP970308A2 publication Critical patent/HRP970308A2/xx
Publication of HRP970308B1 publication Critical patent/HRP970308B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/85Reproductive organs or embryos
    • Y10S530/851Placenta; amniotic fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HR970308A 1996-06-07 1997-06-04 Peptide derivatives HRP970308B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9611881.5A GB9611881D0 (en) 1996-06-07 1996-06-07 Peptide derivatives
GBGB9622890.3A GB9622890D0 (en) 1996-11-02 1996-11-02 Peptide compounds

Publications (2)

Publication Number Publication Date
HRP970308A2 HRP970308A2 (en) 1998-04-30
HRP970308B1 true HRP970308B1 (en) 2002-04-30

Family

ID=26309459

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970308A HRP970308B1 (en) 1996-06-07 1997-06-04 Peptide derivatives

Country Status (21)

Country Link
US (2) US6541453B2 (de)
EP (1) EP0914333B1 (de)
JP (1) JP2000512277A (de)
KR (1) KR100451522B1 (de)
CN (1) CN1130372C (de)
AR (1) AR008389A1 (de)
AT (1) ATE283278T1 (de)
AU (1) AU727757B2 (de)
BR (1) BR9709533A (de)
CA (1) CA2252417A1 (de)
DE (1) DE69731747T2 (de)
HR (1) HRP970308B1 (de)
ID (1) ID17440A (de)
IL (1) IL127332A0 (de)
NO (1) NO985680L (de)
NZ (1) NZ332347A (de)
PL (1) PL330348A1 (de)
SK (1) SK166798A3 (de)
TR (1) TR199802537T2 (de)
TW (1) TW474947B (de)
WO (1) WO1997046578A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9809021D0 (en) * 1998-04-29 1998-06-24 Zeneca Ltd Chemical process
CA2386398A1 (en) * 1999-10-18 2001-04-26 Akzo Nobel Nv Modified peptides and peptidomimetics for use in immunotherapy
JP2008188285A (ja) * 2007-02-06 2008-08-21 Bridgestone Corp バックパッド及び車両用シート
BRPI0918868B8 (pt) 2008-09-18 2021-05-25 Naurex Inc compostos moduladores do receptor de nmda e composições compreendendo os mesmos
US8951968B2 (en) 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
WO2011100585A1 (en) 2010-02-11 2011-08-18 Joseph Moskal Secondary structure stabilized nmda receptor modulators and uses thereof
KR101692275B1 (ko) 2010-02-11 2017-01-04 노오쓰웨스턴 유니버시티 2차 구조 안정화된 nmda 수용체 조절제 및 그의 용도
EP2951186B1 (de) 2013-01-29 2018-07-25 Aptinyx Inc. Spiro-lactam-nmda-rezeptormodulatoren und verwendungen davon
US9758525B2 (en) 2013-01-29 2017-09-12 Aptinyx Inc. Spiro-lactam NMDA receptor modulators and uses thereof
PE20151416A1 (es) 2013-01-29 2015-10-10 Naurex Inc Moduladores de receptores nmda de espiro-lactama y sus usos
KR102410989B1 (ko) 2013-01-29 2022-06-17 앱티닉스 인크. 스피로-락탐 nmda 수용체 조절인자 및 그의 용도
JP2016506962A (ja) 2013-01-29 2016-03-07 ノーレックス, インコーポレイテッドNaurex, Inc. スピロラクタム系nmda受容体モジュレーターおよびその使用
PE20190174A1 (es) 2016-05-19 2019-02-01 Aptinyx Inc Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos
WO2017201285A1 (en) 2016-05-19 2017-11-23 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
JP7036792B2 (ja) 2016-08-01 2022-03-15 アプティニックス インコーポレイテッド スピロ-ラクタムnmda受容体修飾因子およびその使用
IL286107B2 (en) 2016-08-01 2024-09-01 Aptinyx Inc Spiro-lactam nmda receptor modulators and usesthereof
WO2018026798A1 (en) 2016-08-01 2018-02-08 Aptinyx Inc. Spiro-lactam nmda modulators and methods of using same
AU2017306158B2 (en) 2016-08-01 2021-10-14 Aptinyx Inc. Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof
KR102465758B1 (ko) 2016-08-01 2022-11-09 앱티닉스 인크. 스피로-락탐 nmda 수용체 조정제 및 그의 용도
PE20210455A1 (es) 2018-01-31 2021-03-08 Aptinyx Inc Moduladores del receptor nmda espiro-lactama y usos de los mismos
CN109115899A (zh) * 2018-06-19 2019-01-01 南京肽业生物科技有限公司 一种Fmoc氨基酸的分析方法
US12012413B2 (en) 2019-11-11 2024-06-18 Tenacia Biotechnology (Hong Kong) Co., Limited Methods of treating painful diabetic peripheral neuropathy
EP4141110A4 (de) 2020-04-24 2025-04-09 Sf Biotech Laboratuvar Danismanlik Anonim Sirketi Verfahren zur herstellung von bakteriophagenteilchen der gattung levivirus

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301151A (en) 1979-11-27 1981-11-17 Merck & Co., Inc. Long-lasting agonists of enkephalin
US4254107A (en) 1979-11-27 1981-03-03 Merck & Co., Inc. Long-lasting agonists of enkephalin
US4474778A (en) 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
US4680283A (en) 1984-09-26 1987-07-14 Merck & Co., Inc. Analogs of substance P and eledoisin
DE3711335A1 (de) 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5331089A (en) 1988-03-25 1994-07-19 Merck Sharpe & Dohme, Ltd. Peptides useful as tachykinin agonists
EP0360390A1 (de) 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactamderivate
WO1990003399A1 (en) * 1988-09-30 1990-04-05 Australian Commercial Research & Development Limited Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer
US5223485A (en) 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
AU8305491A (en) 1990-08-01 1992-03-02 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
AU2468392A (en) 1991-08-29 1993-04-05 Cytel Corporation Novel immunosuppressants
ATE170868T1 (de) 1993-06-04 1998-09-15 Vertex Pharma Peptid-phosphinyloxymethyl-ketonen als inhibitoren von interleukin-1 beta- konvertierenden enzymen
DE69435171D1 (de) 1993-09-14 2009-01-08 Pharmexa Inc Pan dr-bindeproteinen zur erhöhung der immunantwort
CA2186873A1 (en) * 1994-04-01 1995-10-12 Charles J. Hackett Haptenated peptides and uses thereof
EP0815123B1 (de) 1995-03-24 2001-10-04 Molecumetics, Ltd. Beta-schleifenähnliche verbindungen und deren verwendung als protease-inhibitoren
US5719296A (en) 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
US5840835A (en) 1995-10-30 1998-11-24 Merck & Co., Inc. Inhibitors of peptide binding to MHC class II proteins
US5817757A (en) 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
WO1997016425A1 (en) 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
GB9621836D0 (en) 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9625865D0 (en) 1996-12-12 1997-01-29 Zeneca Ltd Peptides

Also Published As

Publication number Publication date
AU2972097A (en) 1998-01-05
AU727757B2 (en) 2000-12-21
CN1221424A (zh) 1999-06-30
CN1130372C (zh) 2003-12-10
WO1997046578A1 (en) 1997-12-11
EP0914333B1 (de) 2004-11-24
TR199802537T2 (xx) 1999-03-22
DE69731747D1 (de) 2004-12-30
SK166798A3 (en) 1999-07-12
AR008389A1 (es) 2000-01-19
HRP970308A2 (en) 1998-04-30
IL127332A0 (en) 1999-09-22
CA2252417A1 (en) 1997-12-11
US20020103335A1 (en) 2002-08-01
NO985680L (no) 1999-02-04
DE69731747T2 (de) 2006-02-02
JP2000512277A (ja) 2000-09-19
PL330348A1 (en) 1999-05-10
NZ332347A (en) 2000-05-26
KR100451522B1 (ko) 2004-12-08
KR20000016465A (ko) 2000-03-25
NO985680D0 (no) 1998-12-04
ATE283278T1 (de) 2004-12-15
US6541453B2 (en) 2003-04-01
TW474947B (en) 2002-02-01
US20030195158A1 (en) 2003-10-16
EP0914333A1 (de) 1999-05-12
ID17440A (id) 1997-12-24
BR9709533A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
HRP970618A2 (en) Antiviral peptide derivatives
HRP970174B1 (en) 6-phenylpyridil-2-amine derivatives
AP9701156A0 (en) 6-phenylpyridyl-2-amine derivatives
HRP970308B1 (en) Peptide derivatives
IL125804A0 (en) Peptide derivatives
HUP9701835A3 (en) Vinyl-pirrolidinone-cephalosporin derivatives
GB9624562D0 (en) Peptide derivatives
HU9701479D0 (en) N-benzylazolium derivatives
GB9604996D0 (en) Benzodiazonine derivatives
ZA9711392B (en) Cyclic peptide derivatives
GB9603226D0 (en) Heterocyclyl-ergoline derivatives
GB9600063D0 (en) Guaridine derivatives
GB9702049D0 (en) Tetrahhydroisoquinoline derivatives
GB9603855D0 (en) Peptide derivatives
GB9611881D0 (en) Peptide derivatives
GB9709607D0 (en) Peptide derivatives
SI0882066T1 (en) Peptide derivatives
HU9601036D0 (en) Aryl-sulfonyl-hydroxamic-acid derivatives
GB9713361D0 (en) Peptide derivatives
AU2233497A (en) Peptide derivatives
GB9605904D0 (en) Peptides
GB9606765D0 (en) Peptides
GB9626362D0 (en) Peptides
GB9625227D0 (en) Peptides
GB9612648D0 (en) Peptides

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20030415

Year of fee payment: 7

PNAN Change of the applicant name, address/residence

Owner name: SYNGENTA LIMITED,\NSYNGENTA EUROPEAN REGIONAL CENT

PPPP Transfer of rights

Owner name: ASTRAZENECA UK LIMITED, GB

PBON Lapse due to non-payment of renewal fee

Effective date: 20040605